SubHero Banner

Avycaz® (ceftazidime/avibactam) – Expanded indication

March 18, 2019 - Allergan announced the FDA approval of Avycaz (ceftazidime/avibactam), for the treatment of complicated intra-abdominal infections (cIAI), used in combination with metronidazole; and in complicated urinary tract infections (cUTI), including pyelonephritis, in adult and pediatric patients 3 months and older caused by susceptible gram-negative microorganisms.

Download PDF